Off-label use of biologic agents in the treatment of dermatosis, part 2: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab, and cetuximab

Actas dermo-sifiliográficas
G GuhlJ Fernández-Herrera

Abstract

In recent years, a series of new drugs have been developed through the application of molecular biology. These drugs act by blocking specific molecules of the immune system and have been developed to act on specific targets that play an important role in the pathophysiology of the diseases in which their therapeutic use has now been approved. Over time, experience has been accumulated in the use of these drugs in the treatment of skin diseases for which they have not been approved but in which the pathophysiology suggests that they could also be effective. The use of these drugs is increasing in difficult-to-treat cases of skin diseases for which the drugs are not approved. The second part of this review of off-label use of biologic agents in dermatology considers the use of etanercept, efalizumab, alefacept, rituximab, basiliximab, omalizumab, and cetuximab.

References

May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·K BholA R Ahmed
Oct 23, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D G MaloneyR Levy
Jun 19, 1998·Journal of the American Academy of Dermatology·J BagelJ Nichols
Dec 23, 1999·The New England Journal of Medicine·H MilgromW J Metzger
May 18, 2000·Archives of Dermatology·U MrowietzE Christophers
Jun 9, 2000·Clinical and Experimental Dermatology·C M Owen, P V Harrison
Nov 18, 2000·Bone Marrow Transplantation·M AndolinaG Di Leo
Feb 13, 2001·The British Journal of Dermatology·J WohlrabW C Marsch
Sep 1, 2001·The European Respiratory Journal·M SolèrG Della Cioppa
Oct 31, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·C A EganK B Yancey
Nov 16, 2001·Rheumatology·G S BleuminkB H Stricker
Dec 26, 2001·JAMA : the Journal of the American Medical Association·T B CasaleUNKNOWN Omalizumab Seasonal Allergic Rhinitis Trail Group
Jan 5, 2002·Journal of the American Academy of Dermatology·Christopher SacherNicolas Hunzelmann
Jul 19, 2002·Arthritis and Rheumatism·Annette D WagnerHenning Zeidler
Aug 8, 2002·Archives of Dermatology·Alfredo ReboraGiovanni Murialdo
Aug 16, 2002·Transplant Immunology·Russell L DedrickMarvin Garovoy
Aug 29, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·S G O JohanssonPaul M O'Byrne
Sep 5, 2002·Arthritis and Rheumatism·Francesco ZajaMichele Baccarani
Sep 25, 2002·Journal of the American Academy of Dermatology·Stefan DichmannJohannes Norgauer
Oct 16, 2002·Annals of the Rheumatic Diseases·A P CairnsA J Taggart
Dec 5, 2002·Clinical and Experimental Dermatology·J D L Williams, C E M Griffiths
Feb 1, 2003·Blood·Francesco ZajaGianfranco Ferraccioli
Feb 28, 2003·Clinical Rheumatology·M DebandtO Meyer
Feb 28, 2003·Immunobiology·Christian KneitzHans Peter Tony
Mar 26, 2003·The British Journal of Dermatology·G HerrmannA Engert
Apr 11, 2003·Arthritis and Rheumatism·Elise Carlson, Naomi Rothfield
Jun 26, 2003·Clinical and Experimental Dermatology·H L CooperP S Friedmann
Aug 2, 2003·Journal of the American Academy of Dermatology·Ben Goffe, Jennifer Clay Cather

❮ Previous
Next ❯

Citations

May 14, 2009·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·N BookenM Goebeler
Oct 24, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M Augustin
Mar 8, 2011·Actas dermo-sifiliográficas·B EcheverríaF A Kerdel
Apr 24, 2009·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Norbert H BrockmeyerStefanie Reich-Schupke
Apr 15, 2009·Expert Opinion on Pharmacotherapy·Antonella Tosti, Bruna Duque-Estrada
Feb 19, 2009·Dermatologic Therapy·Xinaida T LimaAlexandra B Kimball

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Hematology
Giampaolo TalamoMaurizio Zangari
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Maria KoukoulakiDavid R W Jayne
© 2021 Meta ULC. All rights reserved